Najafzadeh M - Search Results

1

Cost effectiveness of herpes zoster vaccine in Canada.

Najafzadeh M, Marra CA, Galanis E, Patrick DM. Najafzadeh M, et al. Pharmacoeconomics. 2009;27(12):991-1004. doi: 10.2165/11314010-000000000-00000. Pharmacoeconomics. 2009. PMID: 19908924

2

Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada.

Johnston KM, Marra CA, Connors JM, Najafzadeh M, Sehn L, Peacock SJ. Johnston KM, et al. Among authors: najafzadeh m. Value Health. 2010 Sep-Oct;13(6):703-11. doi: 10.1111/j.1524-4733.2010.00737.x. Epub 2010 Jun 7. Value Health. 2010. PMID: 20561333 Free article.

3

Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis.

Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T. Davis JC, et al. Among authors: najafzadeh m. Osteoporos Int. 2011 May;22(5):1355-66. doi: 10.1007/s00198-010-1356-5. Epub 2010 Aug 4. Osteoporos Int. 2011. PMID: 20683707 Free PMC article. Clinical Trial.

4

Technical note: acceptability curves could be misleading when correlated strategies are compared.

Sadatsafavi M, Najafzadeh M, Marra C. Sadatsafavi M, et al. Among authors: najafzadeh m. Med Decis Making. 2008 May-Jun;28(3):306-7. doi: 10.1177/0272989X07312726. Epub 2008 Feb 12. Med Decis Making. 2008. PMID: 18270304 No abstract available.

5

A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework.

Lynd LD, Marra CA, Najafzadeh M, Sadatsafavi M. Lynd LD, et al. Among authors: najafzadeh m. Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1172-80. doi: 10.1002/pds.1994. Pharmacoepidemiol Drug Saf. 2010. PMID: 20602338

6

Sustained economic benefits of resistance training in community-dwelling senior women.

Davis JC, Marra CA, Robertson MC, Najafzadeh M, Liu-Ambrose T. Davis JC, et al. Among authors: najafzadeh m. J Am Geriatr Soc. 2011 Jul;59(7):1232-7. doi: 10.1111/j.1532-5415.2011.03474.x. Epub 2011 Jun 30. J Am Geriatr Soc. 2011. PMID: 21718265 Free PMC article. Clinical Trial.

7

Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer.

Najafzadeh M, Marra CA, Lynd LD, Wiseman SM. Najafzadeh M, et al. Value Health. 2012 Dec;15(8):1005-13. doi: 10.1016/j.jval.2012.06.017. Epub 2012 Sep 25. Value Health. 2012. PMID: 23244801 Free article.

8

Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.

Sadatsafavi M, Bansback N, Zafari Z, Najafzadeh M, Marra C. Sadatsafavi M, et al. Among authors: najafzadeh m. Value Health. 2013 Mar-Apr;16(2):438-48. doi: 10.1016/j.jval.2012.10.018. Epub 2013 Jan 26. Value Health. 2013. PMID: 23538197 Free article.

9

Interpretation of results of the cost-effectiveness analysis reported by Pellissier et al. on October 2007.

Najafzadeh M, Sadatsafavi M, Marra CA. Najafzadeh M, et al. Vaccine. 2008 Sep 26;26(41):5244; author reply 5245. doi: 10.1016/j.vaccine.2008.06.063. Epub 2008 Jul 9. Vaccine. 2008. PMID: 18619510 No abstract available.

10

Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.

Najafzadeh M, Marra CA, Sadatsafavi M, Aaron SD, Sullivan SD, Vandemheen KL, Jones PW, Fitzgerald JM. Najafzadeh M, et al. Thorax. 2008 Nov;63(11):962-7. doi: 10.1136/thx.2007.089557. Epub 2008 Jul 11. Thorax. 2008. PMID: 18621985 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters